BCLSI
Bain Capital Life Sciences Investors’s Nautilus Biotechnolgy NAUT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,072,421
| Closed | -$923K | – | 24 |
|
|
2025
Q1 | $923K | Sell |
1,072,421
-686,579
| -39% | -$591K | 0.14% | 23 |
|
|
2024
Q4 | $2.96M | Sell |
1,759,000
-241,000
| -12% | -$405K | 0.35% | 22 |
|
|
2024
Q3 | $5.7M | Hold |
2,000,000
| – | – | 0.59% | 20 |
|
|
2024
Q2 | $4.68M | Hold |
2,000,000
| – | – | 0.51% | 20 |
|
|
2024
Q1 | $5.88M | Hold |
2,000,000
| – | – | 0.47% | 23 |
|
|
2023
Q4 | $5.98M | Hold |
2,000,000
| – | – | 0.57% | 23 |
|
|
2023
Q3 | $6.32M | Hold |
2,000,000
| – | – | 0.71% | 25 |
|
|
2023
Q2 | $7.74M | Hold |
2,000,000
| – | – | 0.8% | 24 |
|
|
2023
Q1 | $5.54M | Hold |
2,000,000
| – | – | 0.69% | 28 |
|
|
2022
Q4 | $3.6M | Hold |
2,000,000
| – | – | 0.4% | 29 |
|
|
2022
Q3 | $4.24M | Hold |
2,000,000
| – | – | 0.51% | 29 |
|
|
2022
Q2 | $5.38M | Hold |
2,000,000
| – | – | 0.63% | 27 |
|
|
2022
Q1 | $8.68M | Hold |
2,000,000
| – | – | 0.84% | 24 |
|
|
2021
Q4 | $10.4M | Hold |
2,000,000
| – | – | 0.82% | 23 |
|
|
2021
Q3 | $12.3M | Hold |
2,000,000
| – | – | 0.76% | 22 |
|
|
2021
Q2 | $20.2M | Buy |
2,000,000
+1,000,000
| +100% | +$10.1M | 1.32% | 17 |
|
|
2021
Q1 | $13.8M | Hold |
1,000,000
| – | – | 0.78% | 22 |
|
|
2020
Q4 | $10.9M | Hold |
1,000,000
| – | – | 0.68% | 19 |
|
|
2020
Q3 | $10.8M | Buy |
+1,000,000
| New | +$10.8M | 1.01% | 19 |
|